Earnings release
Page 1
EX - 99.1 2 d21980dex991.htm EX - 99.1 ResMed For investors Amy Wakeham +1 858-836-5000 investorrelations@resmed.com Second Quarter 2021 Highlights All comparisons are to the prior year period For media Jayme Rubenstein +1 858-836-6798 news@resmed.com ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2021 Year - over - year revenue grows 9 % , operating profit up 12 % , non - GAAP operating profit up 16 % Note : A webcast of ResMed's conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO , January 28 , 2021 – ResMed Inc. ( NYSE : RMD , ASX : RMD ) , a world - leading digital health company , today announced results for its quarter ended December 31 , 2020 . ● Exhibit 99.1 Revenue increased 9 % to $ 800.0 million ; up 7 % on a constant currency basis GAAP gross margin of 57.8 % ; non - GAAP gross margin expanded 20 bps to 59.9 % Net operating profit increased 12 % ; non - GAAP operating profit up 16 % GAAP diluted earnings per share of $ 1.23 ; non - GAAP diluted earnings per share of $ 1.41 " Our second - quarter results reflect continued solid performance and positive trends across our business resulting in top - line growth as well as double digit improvement in operating income and earnings per share , " said Mick Farrell , ResMed CEO . " In our core markets of sleep apnea , COPD , and asthma , we are seeing continued sequential improvement in new patient volume and ongoing adoption of our mask and accessories resupply programs . Our global teams have managed SG & A investments judiciously as we navigate through the global pandemic . We have seen great adoption of digital health and an increase in the importance of out - of - hospital healthcare these last 12 months , and that will only expand throughout 2021 as vaccines become more widely available , and our communities open up worldwide . We have continued to invest in focused R & D programs in digital health and core medtech innovation , to help accelerate our ResMed growth strategy : improving 250 million lives in out - of - hospital healthcare in 2025. "